A

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Accounting Manager

Financial AccountingConfirmed live in the last 24 hours
Full-timeNew York, NY, USAHybrid

About the Job

Requirements

  • A bachelor's degree in accounting or finance is required.
  • Certified Public Accountant credential is required.
  • At least 6 years of progressive accounting experience in the biotech industry or at Big Four accounting firms is required.
  • Ability to work on site Monday, Tuesday, and Thursday is required; fully remote candidates are not considered.
  • Strong understanding of accounting systems, generally accepted accounting principles, and Securities and Exchange Commission reporting requirements.
  • Proficiency in Microsoft Office and accounting systems such as Microsoft Dynamics.
  • Ability to multitask in a fast-paced environment with minimal direction and adjust workload based on changing priorities.
  • Strong interpersonal, verbal, and written communication skills.
  • Ability to collaborate within a growing organization.
  • Strategic and analytical thinking, with the ability to influence and partner.

Responsibilities

  • Plan, direct, and coordinate all accounting functions.
  • Review existing processes and functions for automation, enhancements, and improvements, including enterprise resource planning, procure-to-pay, and order-to-cash processes and systems.
  • Manage monthly and quarterly close processes and consolidate financial data required for accurate financial statements and reporting.
  • Assist with budgeting and forecasting processes and prepare variance analyses comparing budgets and forecasts with actual results.
  • Support financial reporting for Securities and Exchange Commission filings, including Forms 10-Q and 10-K and proxy statements, and review external communications such as press releases, earnings releases, prepared remarks, and corporate presentations.
  • Research and document accounting positions and provide support for technical accounting memoranda under United States generally accepted accounting principles.
  • Coordinate quarterly reviews and annual audits with external auditors.
  • Coordinate tax compliance tasks with external tax accountants, provide information for periodic tax reporting and annual federal, state, local, and international tax returns, and review supporting tax schedules and filings.
  • Participate in preparing and documenting Sarbanes-Oxley narratives, developing control evidence expectations and detailed testing plans, and reviewing test guidance and scripts for completeness and accuracy.
  • Support planning, facilitate, and provide guidance for management's execution and verification of internal-controls-over-financial-reporting assessments in accordance with the company's control assessment approach.
  • Manage equity plan administration, including fair market value calculations using the Black-Scholes model with a third-party vendor; issuance of new grants, exercises, cancellations, and forfeitures; and processing grants in the online equity system.
  • Provide management with financial information to support decision-making, including ad hoc and management reports.
  • Provide leadership and influence key decisions related to overall business needs and the accounting and finance function.

About the Company

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Axsome Therapeutics develops therapies for central nervous system disorders. Its focus is on research, development, and commercialization of treatments for conditions such as major depressive disorder, treatment-resistant depression, Alzheimer's agitation, migraine, narcolepsy, fibromyalgia, and smoking cessation. The flagship product candidate, AXS-05, is an oral NMDA receptor antagonist intended to treat MDD and TRD; it works by blocking NMDA receptors to influence brain signaling involved in mood and depression, and has received FDA Breakthrough Therapy Designation. The company earns revenue from the commercialization of its drugs, partnerships, and potential licensing deals as its pipeline progresses through clinical trials and regulatory approvals. Axsome aims to provide effective CNS therapies, advance its drug pipeline, and improve patient outcomes and quality of life.

Company size
501-1,000
Company stage
IPO
Headquarters
New York City, New York
Founded
2012

Recently Posted Jobs

Explore more opportunities at Axsome Therapeutics

See more jobs